Company / Free Cash Flow
MARAVAI LIFESCIENCES HOLDINGS, INC. Free Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$70.7M
FY2025
5-year range
-$70.7M / $518.9M
FY2021-FY2025
Trend
-218.7%
vs FY2024
Sector context
#90 of 194
Health Care
What the data says
Free Cash Flow changed -219% YoY in FY2025, a notable deviation from the 6-year average annual change of +250%.
Based on SEC 10-K filings.
-$71M in FY2025.
Declined from $61M to -$71M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#90 of 194 in Health CareTop 46% of 194This company -$70.7M Sector average $470.6M
▼
-115.0% below sector average
Key checks
Key Insights
- MARAVAI LIFESCIENCES HOLDINGS, INC.'s free cash flow has declined for 3 consecutive years.
- In FY2025, free cash flow decreased 218.7% year-over-year.
- Ranks #90 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$70.7M | -218.7% |
| FY2024 | -$22.2M | -136.6% |
| FY2023 | $60.7M | -88.3% |
| FY2022 | $518.9M | +46.7% |
| FY2021 | $353.7M | +179.0% |
| FY2020 | $126.8M | +1719.7% |
| FY2019 | $7.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026